Form 8-K - Current report

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): January 8, 2024                                                                                                                                                    

   

Alignment Healthcare, Inc.

(Exact name of Registrant as Specified in Its Charter)


Delaware	001-40295	46-5596242
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1100 W Town and Country Road Suite 1600
Orange, California		92868
(Address of Principal Executive Offices)		(Zip Code)

    Registrant’s Telephone Number, Including Area Code: 844 310-2247

   

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	ALHC	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

Members of Alignment Healthcare, Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at an industry conference and various other meetings on January 8-11, 2024. During the conference and meetings, the Company intends to address aspects of its prospects and performance as described below. The date and time of presentations to investors are available via the Investor Relations calendar of events and presentations on the Company's website at www.alignmenthealth.com. The Company’s presentation during the industry conference on January 10, 2024 is expected to be webcast and a replay will be available on the Company's Investor Relations website.

Update on 2024 Membership Outlook, 2024 Profitability Expectations and Full-Year 2023 Guidance

The Company has completed the Annual Enrollment Period ("AEP") for 2024 and currently estimates that it will have approximately 155,500 members enrolled in its HMO and PPO contracts ("Health Plan Members") as of January 1, 2024. This figure represents Health Plan Member growth of approximately 44% year over year when compared with the Company's Health Plan Membership as of January 1, 2023. Additionally, the Company expects to have 162,000 to 164,000 members as of December 31, 2024, representing approximately 38% growth relative to the midpoint of the Company’s latest Health Plan Membership guidance for year-end 2023 provided on November 2, 2023.

Additionally, the Company expects the midpoint of its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) guidance to be breakeven in 2024. The Company expects to provide its full 2024 guidance on its fourth quarter 2023 earnings call.

Lastly, the Company is reaffirming its revenue, adjusted gross profit and adjusted EBITDA financial guidance ranges for the fiscal year ended December 31, 2023, and additionally expects adjusted EBITDA results to fall at the low-end of its guidance range. The Company’s updated adjusted EBITDA expectations reflect decisions to increase discretionary investments in sales and marketing during the back-half of AEP given the significant growth opportunity the Company was presented with during AEP. As a result of the Company’s robust growth achievement, the Company also accelerated new hires and clinical investments in December to support the onboarding of its January 1, 2024 membership.

The 2023 financial guidance was previously issued in the Company’s press release dated November 2, 2023, as follows:


$ Millions	Low	High
Revenue	$1,780	$1,800
Adjusted Gross Profit1	$206	$214
Adjusted EBITDA2	($34)	($26)

Adjusted gross profit is a non-GAAP financial measure that is presented as supplemental disclosure, that the Company defines as loss from operations before depreciation and amortization, clinical equity-based compensation expense, and selling, general, and administrative expenses. The Company cannot reconcile its estimated ranges for adjusted gross profit to loss from operations, the most directly comparable GAAP measure, and cannot provide estimated ranges for loss from operations, without unreasonable efforts because of the uncertainty around certain items that may impact loss from operations, including equity-based compensation expense and depreciation and amortization, that are not within its control or cannot be reasonably predicted.

Adjusted EBITDA is a non-GAAP financial measure that is presented as supplemental disclosure, that the Company defines as net loss before interest expense, income taxes, depreciation and amortization expense, reorganization and transaction-related expenses, acquisition expenses, certain litigation costs and settlements, gains or losses from subleases and equity-based compensation expense. The Company cannot reconcile its estimated ranges for Adjusted EBITDA to net loss, the most directly comparable GAAP measure, and cannot provide estimated ranges for net loss, without unreasonable efforts because of the uncertainty around certain items that may impact net loss, including equity-based compensation expense and depreciation and amortization, that are not within its control or cannot be reasonably predicted.

The Company believes that non-GAAP financial measures provide an additional way of viewing aspects of its operations that, when viewed with GAAP results, provide a more complete understanding of its results of operations and the factors and trends affecting its business. These non-GAAP financial measures are also used by its management to evaluate financial results and to plan and forecast future periods. However, non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. For more information on the Company’s use of non-GAAP financial measures, please refer to its SEC filings, which are available on its Investor Relations site at alignmenthealth.com. The Company will not be providing any GAAP or other financial information with respect to its fourth quarter earnings at this time as it is in the process of closing its books for fiscal year 2023.

Management Presentation

On January 8, 2024, the Company posted a presentation in the “Investor Relations” portion of the Company's website at www.alignmenthealth.com. The Company’s intends give this presentation during meetings with investors and analysts at the

industry conference and in various other meetings on January 8-11, 2024. A copy of the presentation is attached and furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Cautionary Statement

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the Company's ability to attract new members and enter new markets, including the need for certain governmental approvals; its ability to maintain a high rating for its plans on the Five Star Quality Rating System; our ability to develop and maintain satisfactory relationships with care providers that service our members; risks associated with being a government contractor; changes in laws and regulations applicable to its business model; risks related to its indebtedness, including the potential for rising interest rates; changes in market or industry conditions and receptivity to its technology and services; results of litigation or a security incident; and the impact of shortages of qualified personnel and related increases in its labor costs. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in its Annual Report on Form 10-K for the year ended December 31, 2022, and the other periodic reports it files with the SEC. All information provided in this Current Report on Form 8-K is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law.

The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits



Exhibit No.	Description
99.1	Alignment Healthcare, Inc. Investor Presentation dated January 8, 2024
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


			ALIGNMENT HEALTHCARE, INC.

Date:	January 8, 2024	By:	/s/ Thomas Freeman
			Thomas Freeman Chief Financial Officer

DELIVERING A BREAKTHROUGH YEAR A NEW ERA OF AGING © 2024 Alignment Healthcare USA, LLC. All Rights Reserved. Alignment Healthcare is a registered trademark with the U.S. Patent and Trademark Office. Exhibit 99.1

Legal Disclaimer Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the Company's ability to attract new members and enter new markets, including the need for certain governmental approvals; its ability to maintain a high rating for its plans on the Five Star Quality Rating System; our ability to develop and maintain satisfactory relationships with care providers that service our members; risks associated with being a government contractor; changes in laws and regulations applicable to its business model; risks related to its indebtedness, including the potential for rising interest rates; changes in market or industry conditions and receptivity to its technology and services; results of litigation or a security incident; and the impact of shortages of qualified personnel and related increases in its labor costs. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in its Annual Report on Form 10-K for the year ended December 31, 2022, and the other periodic reports it files with the SEC. All information provided in this Current Report on Form 8-K is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law. This presentation includes certain market and industry data and statistics, which are based on publicly available information, industry publications and surveys, reports from government agencies, reports by market research firms and our own estimates based on our management’s knowledge of, and experience in, the industry and market in which we compete. Third-party industry publications and forecasts have been obtained from sources we generally believe to be reliable. In addition, certain information contained in this presentation represents management estimates. While we believe our internal estimates to be reasonable, they have not been verified by any independent sources. Such data involve risks and uncertainties and are subject to change. This presentation contains certain “non-GAAP” financial measures within the meaning of Item 10 of Regulation S-K promulgated by the SEC. We believe that non-GAAP financial measures provide an additional way of viewing aspects of our operations that, when viewed with the GAAP results, provide a more complete understanding of our results of operations and the factors and trends affecting our business. These non-GAAP financial measures are also used by our management to evaluate financial results and to plan and forecast future periods. However, non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Non-GAAP financial measures used by us may differ from the non-GAAP measures used by other companies, including our competitors. To supplement our consolidated financial statements presented on a GAAP basis, we disclose the following non-GAAP measures: Medical Benefits Ratio, Adjusted EBITDA and Adjusted Gross Profit, as these are performance measures that our management uses to assess our operating performance. Because these measures facilitate internal comparisons of our historical operating performance on a more consistent basis, we use these measures for business planning purposes and in evaluating acquisition opportunities. For a reconciliation of these non-GAAP measures to the corresponding measures calculated in accordance with GAAP, see the Appendix to this presentation.

Establishing a New Paradigm Exceptional 2024 AEP Results ~155,500 health plan members as of Jan. 1, 2024 (YoY net membership adds of 47,200 implies 44% YoY growth) Increasing market share with 82% of growth from plan switchers California markets comprise 86% of AEP sales Investments in AVA, network, sales operations and member experience leading to a 24% reduction YoY in 1/1 disenrollment 2024 AdjustedEBITDA Breakeven Consistent benefit levels in 2024 underpin strong AEP membership growth Positive year-one membership gross margin pmpm experience supports 2024 Adjusted EBITDA breakeven trajectory Membership growth and increasing density in newer markets support enterprise SG&A leverage opportunity Continuous cohort MBR improvement opportunities Favorable 2025 Outlook Alignment tailwinds versus competitor headwinds Widening stars payment advantages in California Continued phase-in of risk model changes 2025 growth opportunity, cohort margin improvements, investments in AVA and other core infrastructure enhancements driving 2025 profitability outlook Successful 2024 Annual Enrollment Period (AEP) and Operational Execution Lay Foundation for Favorable 2024 / 2025 Outlook

Curated Products tailored to senior lifestyles High-quality provider networks Concierge-level support for a premium member experience Improve health outcomes through AVA insights and Care Anywhere clinical intervention Medical savings result from lowering avoidable costs Reinvestment into superior products using savings derived from medical savings Product and Network Control MA Platform Enables Virtuous Cycle Alignment Virtual Application (AVA): Purpose-built technology platform Detailed, real time member data to support health plan operations Actionable insights enable timely medical intervention by our Care Anywhere teams Data Proximity and Richness: AVA Care Anywhere (CAW): Employed clinical teams who act on AVA insights Engage proactively with our highest-risk seniors to improve member health Agile teams deployed at home and virtually Capital Efficient Clinical Engagement: CAW 1 2 3 4 Payvider Model: Visibility, Control and Durability

Purpose-Built Medicare Advantage Platform Company DRIVES SUSTAINABLE GROWTH PERSONALIZED CARE SUPERIOR EXPERIENCE AND ENGAGEMENT RICHEST COVERAGE AND BENEFITS HIGH-QUALITY, LOW-COST CARE 1 2 3 4 5 AVA Technology Developed deeper provider relationships Bolstered 24/7 concierge services Addressed member townhall feedback Insourced member experience functions Enhanced supplemental vendor management Streamlined 2024 product benefits Increased employed Care Anywhere clinical staff and engagement Invested in Stars capabilities YoY net membership adds of 47,200 as of Jan. 1, 2024, implies 44% YoY growth Ensured YoY benefit stability Launched co-branded relationships Invested in curated, ethnic-oriented products Virtuous Cycle: Doing Well by Doing Good

Creates Visibility, Control, and Durability Across Value Drivers Required for Success AVA Platform Performance ManagementReal-time outcome tracking and performance measurement across value drivers Unified Data Platform Actionable Data and Insights | Accurate, Timely, Complete Core Infrastructure Applications Integrated applications and data across the company Value Drivers Product • Sales • Retention • Stars • Risk Adjustment • Utilization • Unit Cost • G&A Scale Growth Applications Broker and member portals Quality / Risk Adjustment Applications Timely, complete, accurate and compliant documentation Quality / Stars Applications Effective quality program management Care Management Applications Population health and care management

74% MEMBERSHIP 5% INSTITUTIONAL CLAIMS 7% MEMBERSHIP 19% INSTITUTIONAL CLAIMS 7% MEMBERSHIP 1% INSTITUTIONAL CLAIMS HEALTHY PRE-CHRONIC HEALTHY UTILIZER Notes: Based on at-risk members, Aug 2022 - Jul 2023 dates of service. Based on October 2022 to September 2023 encounter data. Estimated number of visits per year includes members who had an initial CAW visit plus estimates including program-based follow-up activities and engagement (telephonic and virtual). 12% MEMBERSHIP 74% INSTITUTIONAL CLAIMS 74% MEMBERSHIP 5% INSTITUTIONAL COSTS 26% MEMBERSHIP 95% INSTITUTIONAL COSTS Average Member Primary Care Physician (PCP) Visits Per Year: ~5 (2) CHRONIC Estimated Care Anywhere Member Touches Per Year: ~25 (3) Care Anywhere Team Physician Social Worker Advanced Practice Clinician Case Manager Proactive Outreach | 24/7 access | Enhanced Care Coordination Behavioral Health Coach Care Coordinator MedicalAssistant We Manage Cost by Managing Care AVA | Member Risk Stratification AVA stratifies members into risk categories; Care Anywhere teams proactively target interventions for chronic, high-risk members (1)

Early Identification by AVA & Proactive Engagement by Care Anywhere Notes: Care Anywhere eligible and enrolled members as of January 2020 through July 2022. Average changes in expenses 12-months before and after date of eligibility or enrollment. Includes members with at least 12 months of “pre” and “post” data The percentage of members identified as high-risk who have an inpatient admission over a 30-day period Change in Institutional Claims Expense 12-Months Following Care Anywhere Enrollment or Eligibility1 (lower is better) (but not enrolled) 30% Net Improvement AVA Inpatient Admission Recall Rate 30-day admission prediction model AVA’s predictive models are highly accurate at forecasting inpatient events … … enabling our Care Anywhere teams to support our sickest members and improve health outcomes Leads to Better Outcomes for our Most Vulnerable Members

Key Value Drivers Continuous Improvements to AVA Across Value Drivers IPO March 2021 Panel Management October 2021 Eligibility and Benefits August 2022 Utilization Management August 2022 Sales Retention Stars Risk Code Completion Utilization OpEx Leverage Broker Intelligence January 2023 Today January 2024 Enable Enhancements to our Virtuous Cycle CRM January 2022 Provider Data Platform January 2023 Case Management September 2023 AVA Modules & Applications Developed Since IPO

Leading with Outstanding Quality >90% of Members in 4+ Star Plans Replicating Results in New Markets Delivering a Premium Member Experience Materializing Higher Member Retention >60 NPS | 4.9 Star Google Rating 4.5 Star Rating in NC and NV 40% Lower Voluntary Disenrollment vs. Industry Alignment has achieved ~155 to 165 Admissions / K over the past 6 years Inpatient Admissions / K 12% MBR Savings Quality and Experience Clinical Outcomes Financial Results 5-Year Membership Compound Annual Growth Rate (CAGR) 2022A 2023E Medicare Advantage MBR 86.1% 87.4% Notes: NPS based on Deft Research’s 2021 Medicare Member Experience Study. Google Rating based on Alignment Health Corporate HQ rating; composite of more than 2,300 ratings as of Dec 23 Voluntary disenrollment based on CY21 CMS Stars reporting for H3815 and national avg. Illustrative MBR savings based on approximate average unit cost per admission/event 1 2 4 4. Medicare FFS data represents 2019 Medicare FFS using ALHC’s 2021 membership mix by county; ALHC data represents YTD 2023 At-Risk member utilization metrics as of September 30, 2023. 5. Defined as total medical expenses excluding depreciation and equity-based compensation divided by total revenues, excluding ACO REACH. 2023E represents the midpoint of Low/High guidance provided November 2, 2023 6. ALHC CAGR based on the midpoint of 2024 year-end membership guidance provided as of January 8, 2024 3 5 Alignment Healthcare Delivers Industry-Leading Results 6

Our Durable Growth Engine is Just Getting Started 155,500 Health Plan Seniors as of Jan. 1, 2024 ~30% mix of dual-eligible & C-SNP 53 Markets Across CA, NC, NV, AZ, TX, FL >1,500 Employees >400 Clinical + Tech Employees Notes: Health plan membership excludes members in RBO and excludes ACO REACH members. 2023E reflects Low/High year-end membership and revenue guidance as of November 2, 2023 2024E reflects Low/High year-end membership guidance as of January 8, 2024 ALHC CAGR based on the midpoint of 2024 year-end membership guidance provided as of January 8, 2024 27% 5-Year Membership CAGR4vs. Industry at 8.6% 2 3 Guided Year-End Health Plan Members1 Reported Year-End Health Plan Members1 Total Revenue

Retention and Member Experience: Insourced call center and improved supplemental benefit vendor management Sales Operations: Hired key sales personnel and improved local sales activities Product Leadership: Enhanced market-level bid tactics and simplified benefits Durable and Aligned Networks: Accelerated local provider engagement Successful Execution of Operational Initiatives… 1 Stars: California competitor Star ratings dropping significantly while ALHC maintains 4 Stars in CA Risk Model: We are relatively advantaged amidst risk model changes Care Model: AVA & Care Anywhere allow us to control medical utilization of highest-cost members relative to elevated industry trends Margin Focused: We remained disciplined during previously aggressive bid dynamics ... Resulted in Favorable Competitive Tailwinds 2 Focused Investments and Execution Establish Durable Competitive Advantages Stars Tracking and Transparency: Focused clinical and operational resources on Stars execution

Industry-Leading 2024 Growth Notes: Calculated as the number of members disenrolling as of January 2024, divided by the total number of unique members +44% Membership Growth Percentage of 2024 AEP Sales byPrior Enrollment Status 82% of Sales from Competing Plans Curated Products, Sales Execution and Brand Recognition Drive Robust Growth Supported by Retention Improvements Resulting from Excellent Service Meaningful Market Share Gains from Competitors 24% Reduction in 1/1 Disenrollment AEP (Jan 1) Disenrollment Trends 1 Results in Meaningful Market Share Gains 1 2 3 Jan 1 Medicare Advantage Enrollment

Notes: 2024 vs 2023, weighted by Alignment’s estimated January 1 membership by plan ID Weighted average of full-year 2021 to 2023, excludes stock-based compensation and depreciation embedded in medical expense Calculated as adjusted selling, general and administrative expenses divided by total revenue excluding ACO REACH Member growth represents year-over-year Medicare Advantage health plan membership growth as of December in years 2022-2024E 2023E reflects Low/High guidance as of November 2, 2023; 2024E reflects Low/High guidance as of January 8, 2024 AEP Growth Supports 2024 Adjusted EBITDA Breakeven Target… Consistent Product Value YoY +0.7% 2 3 Not Increasing Benefits Dramatically from 2023 to 2024… Change in Weighted Average Actuarial Benefit Value1 Positive New Member Gross Profits Demonstrated by Historical Experience and Expected to Continue in 2024 Historical Year 1 Membership Gross Margin2 $89 pmpm Continued Operating Leverage in 2024 3, 4, 5 Supported by Successful 2024 AEP TBA 3 5 … While Growing Membership 44% YoY 1 14% HP Member Gr. 20% HP Member Gr. 38% HP Member Gr. Our care model, AVA technology, provider engagement and member experience deliver profitable unit economics and scalable growth 5

Consistently improving at-risk MBRs over time across vintages Efficacy of operating model demonstrated across cohorts consisting of different mixes of members by product, market and provider group … Combined with Continuous Cohort MBR Improvement Opportunities Notes: ALHC At-Risk data reflects 2014- July 2023 dates-of-service. Claims paid through October 2023. Based on continuous At-Risk membership / market performance. At-risk defined as a member where Alignment manages and is at-risk for the institutional claims. CA pro forma to reflect 4.0 Stars; historical NC RBO shown based on estimated gross revenue. Reflects Part C third party medical expense relative to Part C revenue, including annual clinical model investments. MBR by Member Cohort Year1 At-Risk Member Experience Year 1 vs. Most Recent Cohort Year MBR1 At-Risk Member Experience Historical cohort performance supports 2024 adjusted EBITDA target 2024 sales create significant 2025 cohort improvement opportunity 700 bps better 85% ALHC At-Risk (Actual Experience)1

2022 2023 2024 2023 2024 2025 Widening Stars Advantage in 2025 Notes: Membership data as of December of each year Percentage of Competitor California Membership in Plans Rated 4 Stars or Greater 1 Rating Year Payment Year Supports California Growth Outlook 100% for Total Company 94% for Total Company 92% for Total Company

Disruptive, purpose-built Medicare Advantage platform Delivering A Breakthrough Year Investments in operations and AVA accelerating our virtuous cycle Durable growth supports 2024 Adjusted EBITDA breakeven target Widening competitive advantage versus incumbents (Stars, Risk Adjustment) Favorable 2025 outlook: Cohort improvements and robust growth opportunities Strategic Decisions and Execution Converging to Drive Long-Term Success

Cover	Jan. 08, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Jan. 08, 2024
Entity File Number	001-40295
Entity Registrant Name	Alignment Healthcare, Inc.
Entity Central Index Key	0001832466
Entity Tax Identification Number	46-5596242
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1100 W Town and Country Road
Entity Address, Address Line Two	Suite 1600
Entity Address, City or Town	Orange
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92868
City Area Code	844
Local Phone Number	310-2247
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	ALHC
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false